Generex Biotechnology Corporation (NASDAQ: GNBT), a leader in the area of buccal drug delivery, announced today that it has been awarded its first Japanese patents and a new United States patent expanding the Company's patent coverage for its oral insulin product, Generex Oral-lyn™.
